Ingevity Corporation

NYSE:NGVT

Chemicals - Specialty

Basic Materials
$58.31 +1.13%

+$0.81 today

Market cap
$1.97B
Beta
1.19
P/E (TTM)
-20.0
EPS (TTM)
-$3.62
52W Low $39.74High $79.29

Volume 0.37M

Average 0.26M

NGVT Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Ingevity CorporationNYSE: NGVT

Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026

Capital expenditures growth accelerates

Q3 FY2026 capital expenditures of $13.7M (cash outflow) rose 15.1% year over year, ahead of the -1.9% change in trailing-twelve-month capital expenditures. Sequentially, it rose 33.0% from the prior quarter. Over 3 fiscal years it compounded at -26.0% a year.

Context

  • Capital expenditures amounted to 4.9% of revenue in FY2025, down 0.6 pp from a year earlier.
  • Capital expenditures grew in size in 0 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +15.1% holds above the trailing-twelve-month pace of -1.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
-$13.7M+33.0% QoQ
Last fiscal yearDec 2025
-$57.7M-25.6% YoY
LTMSep 2026
-$57.9M-1.9% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+15.1%——
1 year-25.6%——
3-year CAGR-26.0%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(57.7M) USD
Year-over-year change
+25.6%

Capital Expenditures vs competitors

How NGVT compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -1.9% is the 6th highest of 11, against a peer median of +8.3%.
  • Capital expenditures amounts to 5.1% of revenue for NGVT, versus a peer median of 3.9%.
NGVT Competitors
Capital Expenditures for NGVT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AAUCAllied Gold CorporationLTM Jun 2026$478.41M USD+42.1%+75.3%32.1%
SKESkeena Resources LimitedLTM Sep 2026CA$430.55M CAD+131.1%+149.9%—
CCThe Chemours CompanyLTM Jun 2026$228M USD-26.9%-11.5%3.9%
OLNOlin CorporationLTM Jun 2026$177.6M USD-4.9%-1.5%2.6%
MTXMinerals Technologies Inc.LTM Apr 2026$111.9M USD+22.6%+9.2%5.3%
ASHAshland Inc.LTM Jun 2026$71M USD-30.4%-4.6%3.9%
IOSPInnospec Inc.LTM Jun 2026$60.6M USD+21.4%+5.9%3.3%
NGVTIngevity CorporationLTM Sep 2026$57.9M USD-1.9%-26.0%5.1%
ELVRElevra Lithium LimitedFY2025A$34.84M AUD-29.8%-43.5%16.8%
KWRQuaker Chemical CorporationLTM Sep 2026$22.23M USD-12.6%+25.1%1.1%
FMCFMC CorporationLTM Mar 2026$15M USD+119.0%-12.2%0.4%
Peer median (excluding NGVT) —+8.3%+2.2%3.9%

Competitors are the stored peer set for NGVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income118.1M211.6M(5.4M)(430.3M)(167.1M)
Depreciation & Amortization109.9M108.8M122.8M108.3M106.4M
Deferred Income Tax(4.6M)(5M)(44.7M)(121.4M)(4.7M)
Stock-Based Compensation12.3M16.1M10.6M11.9M18.3M
Change in Working Capital30.5M(66.5M)(67.8M)(10M)22.7M
Accounts Receivables(13.8M)(42.1M)42.7M38.2M12.2M
Inventory(55.8M)(63.7M)25.8M86.2M40.2M
Accounts Payables14.8M42.7M(14.6M)(63.4M)(2.6M)
Other Working Capital85.3M(3.4M)(121.7M)(71M)(27.1M)
Other Non-Cash Items27.1M48.4M189.6M570.1M355.6M
Operating Cash Flow293.3M313.4M205.1M128.6M331.2M
Capital Expenditures(103.8M)(142.5M)(109.8M)(77.6M)(57.7M)
Acquisitions (Net)0(344.5M)000
Purchases of Investments(35.3M)(77.4M)(2.4M)(300K)(16.4M)
Sales of Investments014.7M31.5M013M
Other Investing Activities500K(2.2M)3.4M(1.6M)3.6M
Investing Cash Flow(138.6M)(551.9M)(77.3M)(79.5M)(57.5M)
Debt Repayment(26M)199M(6.6M)(67.1M)(193.6M)
Common Stock Issued4.7M04.7M01.4M
Common Stock Repurchased(109.4M)(145.2M)(92.1M)(3.1M)(56.3M)
Dividends Paid00000
Other Financing Activities(2.4M)(5.7M)(5.9M)0(3.7M)
Financing Cash Flow(133.1M)48.1M(99.9M)(70.2M)(252.2M)
Effect of Forex Changes(1.7M)(6M)(300K)(4.2M)4.5M
Net Change in Cash19.9M(196.4M)27.6M(25.3M)26M
Free Cash Flow189.5M170.9M95.3M51M273.5M

Ingevity Corporation

NYSE:NGVT

Intrinsic Alpha fair value

Locked

Current Price

$58.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.